technetium tc 99m hydroxymethylene diphosphonate has been researched along with CKD-MBD in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayabuchi, N; Hiromatsu, Y; Ishibashi, M; Kurata, S; Nishida, H | 1 |
| Baba, K; Hiromatsu, Y; Iida, S; Ishibashi, M; Kaida, H; Nishida, H; Okuda, S | 1 |
| Baba, K; Hayabuchi, N; Hiromatsu, Y; Ishibashi, M; Kaida, H; Nishida, H; Okuda, S | 1 |
| Houston, AS; MacLeod, MA | 1 |
| Aoki, J; Endo, K; Higuchi, T; Hirano, T; Inoue, T; Naruse, T; Ueki, K; Wakamatsu, R; Yano, S | 1 |
| de Jonge, FA; Hamdy, NA; Pauwels, EK | 1 |
1 review(s) available for technetium tc 99m hydroxymethylene diphosphonate and CKD-MBD
| Article | Year |
|---|---|
Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failure.
Topics: Amyloidosis; Calcinosis; Chronic Kidney Disease-Mineral and Bone Disorder; Etidronic Acid; Humans; Kidney Failure, Chronic; Organotechnetium Compounds; Radionuclide Imaging; Renal Dialysis; Technetium Tc 99m Medronate | 1991 |
3 trial(s) available for technetium tc 99m hydroxymethylene diphosphonate and CKD-MBD
| Article | Year |
|---|---|
A clinical assessment of the relationship between bone scintigraphy and serum biochemical markers in hemodialysis patients.
Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Biomarkers; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Radionuclide Imaging; Radiopharmaceuticals; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Technetium Tc 99m Medronate | 2004 |
Usefulness of bone uptake ratio of bone scintigraphy in hemodialysis patients.
Topics: Adult; Aged; Alkaline Phosphatase; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Radius; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity; Skull; Technetium Tc 99m Medronate | 2005 |
Usefulness of whole PTH assay in patients with renal osteodystrophy--correlation with bone scintigraphy.
Topics: Adult; Aged; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Male; Middle Aged; Parathyroid Hormone; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2005 |
2 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and CKD-MBD
| Article | Year |
|---|---|
Functional bone imaging in the detection of ischemic osteopathies.
Topics: Barotrauma; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Femur Head Necrosis; Fractures, Ununited; Humans; Kidney Transplantation; Legg-Calve-Perthes Disease; Osteochondritis; Predictive Value of Tests; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Medronate | 1997 |
Pentavalent technetium-99m-dimercaptosuccinic acid scintigraphy in renal osteodystrophy.
Topics: Adult; Bone and Bones; Calcitriol; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Medronate | 1998 |